Terms: = Endocrine gland cancer AND CEACAM5, CEA AND Treatment
429 results:
1. A novel multidrug-resistant cell line from a Chinese patient with pancreatic ductal adenocarcinoma.
Tang H; Miao X; Yu C; Chai C; Su Y; Li L; Yi J; Ye Z; Miao L; Wang Z; Zhang H; Xu H; Zhou W
Sci Rep; 2024 Apr; 14(1):9259. PubMed ID: 38649719
[TBL] [Abstract] [Full Text] [Related]
2. [A Case of Sigmoid Colon cancer with Simultaneous Solitary Adrenal Metastasis Refractory to Preoperative Diagnosis].
Saito T; Shibutani M; Fukuoka T; Kasashima H; Kitayama K; Tamura T; Toyokawa T; Ree S; Tanaka H; Kato M; Hirayama Y; Matsue T; Masuda K; Uchida J; Maeda K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1557-1559. PubMed ID: 38303340
[TBL] [Abstract] [Full Text] [Related]
3. New ceaCAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo.
Jancewicz I; Śmiech M; Winiarska M; Zagozdzon R; Wisniewski P
Cancer Immunol Immunother; 2024 Jan; 73(2):30. PubMed ID: 38279989
[TBL] [Abstract] [Full Text] [Related]
4. Serum cea as a Prognostic Marker for Overall Survival in Patients with Localized Pancreatic Adenocarcinoma and Non-Elevated CA19-9 Levels Treated with FOLFIRINOX as Initial treatment: A TAPS Consortium Study.
Doppenberg D; Stoop TF; van Dieren S; Katz MHG; Janssen QP; Nasar N; Prakash LR; Theijse RT; Tzeng CD; Wei AC; Zureikat AH; Groot Koerkamp B; Besselink MG;
Ann Surg Oncol; 2024 Mar; 31(3):1919-1932. PubMed ID: 38170408
[TBL] [Abstract] [Full Text] [Related]
5. Trajectories of immune-related serum proteins and quality of life in patients with pancreatic and other periampullary cancer: the CHAMP study.
Hau SO; Svensson M; Petersson A; Eberhard J; Jirström K
BMC Cancer; 2023 Nov; 23(1):1074. PubMed ID: 37936126
[TBL] [Abstract] [Full Text] [Related]
6. Cyst fluid glycoproteins accurately distinguishing malignancies of pancreatic cystic neoplasm.
Cui M; Hu Y; Zhang Z; Chen T; Dai M; Xu Q; Guo J; Zhang T; Liao Q; Yu J; Zhao Y
Signal Transduct Target Ther; 2023 Oct; 8(1):406. PubMed ID: 37848412
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic value of pretreatment FDG PET-CT for short-term efficacy of radioactive iodine-125 seed implantation in patients with NSCLC.
Hu T; Shen J; Shao M; Feng X; Lu D; Ding E
Brachytherapy; 2023; 22(6):882-888. PubMed ID: 37758577
[TBL] [Abstract] [Full Text] [Related]
8. Exploring the application value of pro-gastrin-releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma.
Miao Q; Lv X; Luo L; Zhang J; Cai B
Cancer Med; 2023 Oct; 12(19):19576-19582. PubMed ID: 37754747
[TBL] [Abstract] [Full Text] [Related]
9. Mucinous cystadenocarcinoma of the ovary in a 14-year-old girl: a case report and literature review.
Li Q; Zou C; Xu Y; Liu S; Yan T
BMC Womens Health; 2023 Jul; 23(1):382. PubMed ID: 37479970
[TBL] [Abstract] [Full Text] [Related]
10. Significance of multiple tumor markers measurements in conversion surgery for unresectable locally advanced pancreatic cancer.
Nagai M; Nakamura K; Terai T; Kohara Y; Yasuda S; Matsuo Y; Doi S; Sakata T; Sho M
Pancreatology; 2023 Sep; 23(6):721-728. PubMed ID: 37328387
[TBL] [Abstract] [Full Text] [Related]
11. Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma.
Christenson ES; Lim SJ; Durham J; De Jesus-Acosta A; Bever K; Laheru D; Ryan A; Agarwal P; Scharpf RB; Le DT; Wang H
Cancer Res Commun; 2022 Nov; 2(11):1418-1425. PubMed ID: 36970054
[TBL] [Abstract] [Full Text] [Related]
12. Ovarian strumal carcinoid: a case report.
Kanasugi M; Nishiyama H; Sanpei M; Asano S; Honda T
Fukushima J Med Sci; 2023 Apr; 69(1):51-55. PubMed ID: 36878591
[TBL] [Abstract] [Full Text] [Related]
13. A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors.
Floerchinger A; Klein JE; Finkbeiner MSC; Schäfer TE; Fuchs G; Doerner J; Zirngibl H; Ackermann M; Kvasnicka HM; Chester KA; Jäger D; Ball CR; Ungerechts G; Engeland CE
Cell Death Dis; 2023 Feb; 14(2):104. PubMed ID: 36765035
[TBL] [Abstract] [Full Text] [Related]
14. Other markers of medullary thyroid cancer, not only calcitonin.
Censi S; Manso J; Mian C
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36651167
[TBL] [Abstract] [Full Text] [Related]
15. Clinical value of combining serum tumor marker detection with fecal occult blood testing in diagnosing colorectal cancer.
Zhou H; Wang XC; Yuan BB; Lu BB
J Physiol Pharmacol; 2022 Jun; 73(3):. PubMed ID: 36515627
[TBL] [Abstract] [Full Text] [Related]
16. Identification of ceacam5 as a stemness-related inhibitory immune checkpoint in pancreatic cancer.
Shi H; Tsang Y; Yang Y
BMC Cancer; 2022 Dec; 22(1):1291. PubMed ID: 36494785
[TBL] [Abstract] [Full Text] [Related]
17. Lobectomy may be more appropriate for patients with early-stage medullary thyroid cancer older than 60 years old.
Yang B; Niu G; Li X; Ma F; Ma Y; Hu S
Front Endocrinol (Lausanne); 2022; 13():1015319. PubMed ID: 36339396
[TBL] [Abstract] [Full Text] [Related]
18. Primary leiomyosarcoma of ovary: A rare malignancy as an incidental finding.
Raychaudhuri S; Sidam D; Jain M; Chawla R; Pujani M; Wadhwa R
Indian J Pathol Microbiol; 2022; 65(4):938-941. PubMed ID: 36308213
[TBL] [Abstract] [Full Text] [Related]
19. Clinical Study of Anti-PD-1 Immunotherapy Combined with Gemcitabine Chemotherapy in Multiline treatment of Advanced Pancreatic cancer.
Liu Y; Li Y; Du S; Fan L; Wang J
Comput Math Methods Med; 2022; 2022():4070060. PubMed ID: 36110574
[TBL] [Abstract] [Full Text] [Related]
20. A Rare Case of Negative Serum Calcitonin in Metastatic Medullary Thyroid Carcinoma: Diagnosis, treatment, and Follow-Up Strategy.
Licata L; Di Fidio CA; Vacante M; Basile F; Biondi A; Richiusa P; Gurrera A; Ciuni R
Am J Case Rep; 2022 Sep; 23():e935207. PubMed ID: 36088532
[TBL] [Abstract] [Full Text] [Related]
[Next]
